The Future Role of Anti-Tumour Necrosis Factor-α Products in the Treatment of Crohn's Disease Ruud A. van HogezandHein W. Verspaget Leading Article 29 November 2012 Pages: 299 - 305
Proton Pump Inhibitors Paul RichardsonChristopher J. HawkeyWilliam A. Stack Review Article 29 November 2012 Pages: 307 - 335
Disease-Modifying Antirheumatic Drugs Christopher G. JacksonH. James Williams Review Article 29 November 2012 Pages: 337 - 344
Rational Drug Therapy Recommendations for the Treatment of Patients with Sjögren's Syndrome Peter OxholmJan U. PrauseMorten Schiødt Disease Management 29 November 2012 Pages: 345 - 353
Levobupivacaine Karen J. McClellanCaroline M. Spencer Adis New Drug Profile 29 November 2012 Pages: 355 - 362
Amphotericin-B Colloidal Dispersion Rex N. BrogdenKaren L. GoaAllan J. Coukell Adis Drug Evaluation 29 November 2012 Pages: 365 - 383
Dexrazoxane Lynda R. WisemanCaroline M. Spencer Adis Drug Evaluation 29 November 2012 Pages: 385 - 403
Milnacipran Caroline M. SpencerMichelle I. Wilde Adis Drug Evaluation 29 November 2012 Pages: 405 - 427
Omeprazole Heather D. LangtryMichelle I. Wilde Adis Drug Evaluation 29 November 2012 Pages: 447 - 486
Levofloxacin Heather D. LangtryHarriet M. Lamb Adis Drug Evaluation 29 November 2012 Pages: 487 - 515